Compare BWXT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWXT | RGEN |
|---|---|---|
| Founded | 1867 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.4B | 8.2B |
| IPO Year | N/A | N/A |
| Metric | BWXT | RGEN |
|---|---|---|
| Price | $177.18 | $164.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $194.66 | $174.90 |
| AVG Volume (30 Days) | ★ 998.6K | 663.3K |
| Earning Date | 11-03-2025 | 10-28-2025 |
| Dividend Yield | ★ 0.56% | N/A |
| EPS Growth | ★ 10.60 | N/A |
| EPS | ★ 3.34 | 0.03 |
| Revenue | ★ $3,058,850,000.00 | $707,890,000.00 |
| Revenue This Year | $18.91 | $17.84 |
| Revenue Next Year | $16.08 | $12.44 |
| P/E Ratio | ★ $53.18 | $6,537.77 |
| Revenue Growth | ★ 14.01 | 11.74 |
| 52 Week Low | $84.21 | $102.97 |
| 52 Week High | $218.50 | $182.52 |
| Indicator | BWXT | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 47.97 | 56.56 |
| Support Level | $167.03 | $156.01 |
| Resistance Level | $181.01 | $167.74 |
| Average True Range (ATR) | 5.61 | 4.38 |
| MACD | 0.83 | -0.10 |
| Stochastic Oscillator | 60.04 | 75.62 |
BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.